https://www.selleckchem.com/pr....oducts/l-nmma-acetat
The results showed a decrease in blood loss reflected by the differences in the final hematocrit values, as well as decrease in the same per aspirated volume (p = 0.003). No adverse events were found related with the TXA application and no blood transfusions were required in this group, in contrast to the control group where the need for blood transfusion was present in 20% of the intervened participants. LEVEL OF EVIDENCE II This journal requires that authors assign a level of evidence to each article. For a full description of
Like
Comment
Share
